The network formed by Ankaferd Blood Stopper® (ABS) affects the entire physiological hemostasis process without specifically affecting any coagulating factor. Therefore, ABS is effective both in individuals with normal hemostasis parameters and in patients with primary and/or secondary hemostasis insufficieny, including disseminated intravascular coagulation.

ABS provides an effective hemostasis in the following conditions/diseases that prolong bleeding time.

• Von Willebrand
• Afibrinogenemia
• Hemophilia
• Diabetes
• Lack of factor
• Hereditary thrombocytopenia
• In acquired bleeding diathesis due to various systematic diseases (Nephrotic, hepatic insufficiency, etc.)
• In acquired bleeding diathesis due to drug use (Warfarin, Heparin, Aspirin etc.)
• Glanzmann's trhombasthenia